Premier Polyfilm Share Price Target 2026, 2027, 2028, 2029, 2030
- Market Cap
- ₹764 Cr
- Book Value
- ₹14.05
- Stock P/E
- 21.86
- Dividend Yield
- 0.21%
- ROE
- 24.05%
- ROCE
- 30.79%
- PEG Ratio
- 0.72
- EV/EBITDA
- —
Fundamentals from Screener.in, as of 6 Aug 2026. Live price via Yahoo Finance.
Technical snapshot
EOD ·Premier Polyfilm Ltd closed at ₹91.42 on 19 August 2026, up 5.5% on the day, 32.8% above its 50-day average, 2.7% below its 52-week high, with volume at 4.20× its 20-session average.
- RSI 14
- 75.7
- vs 50-day SMA
- +32.8%
- vs 200-day SMA
- +66.1%
- From 52-week high
- -2.7%
- Relative volume
- 4.20×
- 20-day return
- +15.2%
End-of-day prices from exchange-published files (NSE/BSE bhavcopy), updated after market close. Descriptive statistics, not investment advice.
Premier Polyfilm share price today
Premier Polyfilm (BSE: 514354) makes flexible PVC products: vinyl flooring, sheeting and artificial leather cloth. These end up under hospital and office floors, inside vehicle interiors, in furniture upholstery and across a long tail of industrial applications. It is a converter — it buys resin and plasticiser and sells finished sheet — which sets both the ceiling on its margin and the shape of its risk.
At the 6 August 2026 cut-off the share closed at ₹72.58, giving a reconciled market capitalisation near ₹764 crore on trailing EPS of ₹3.32. The live quote above will differ; every figure below is fixed to that session.
The case is currently defined by momentum. The June quarter delivered revenue growth above 34% and profit growth above 51%, which is exceptional for a building materials converter. The shares have more than doubled from a 52-week low of ₹38 and sat about 15% below the ₹85.34 high. The question is what a converter’s earnings are worth when the cycle is running this well.
A converter, not a compounder by default
The distinction matters more here than in most of this batch. Premier Polyfilm does not own a brand a consumer asks for, and it does not sell a specified ingredient a regulator has approved. It buys polymer, processes it, and sells sheet into applications where the buyer is usually a contractor, an OEM or a distributor.
| Feature of the business | How it works here | Effect on economics |
|---|---|---|
| Inputs | PVC resin, plasticisers and additives | Cost moves with crude and petrochemical cycles |
| Process | Calendering and coating into sheet and flooring | Capital employed is real but not enormous |
| Products | Vinyl flooring, sheeting, leather cloth | Mid-value; specification matters more than brand |
| Customers | Contractors, OEMs, distributors, exporters | Price-aware, with limited switching friction |
| Margin structure | Operating margin in the mid-teens | Spread business; volume and spread both matter |
A converter earns well when input costs are stable or falling and demand is strong, because the selling price adjusts more slowly than the raw material. It earns badly when the reverse happens. The five-year average operating margin near 16.2% is the honest through-cycle expectation, and it is worth holding in mind against any single spectacular quarter.
Q1 FY27 was genuinely strong
The June 2026 quarter showed revenue of about ₹100.06 crore against roughly ₹74.44 crore a year earlier, growth near 34.4%. Profit after tax rose about 51.3% to roughly ₹9.08 crore, and EBITDA came in near ₹12.90 crore with the margin widening to about 12.90% from around 12.30%.
| Q1 FY27 measure | Q1 FY26 | Q1 FY27 | Change |
|---|---|---|---|
| Revenue from operations | About ₹74.44 Cr | About ₹100.06 Cr | Up about 34.4% |
| EBITDA | — | About ₹12.90 Cr | Margin about 12.90% |
| EBITDA margin | About 12.30% | About 12.90% | Up roughly 60 basis points |
| Profit after tax | About ₹6.00 Cr | About ₹9.08 Cr | Up about 51.3% |
One reconciliation note, because the published figures disagree. Screener records sales of about ₹87.92 crore for the same quarter, against the ₹100.06 crore in the company’s release and contemporaneous coverage. We have used the higher figure because it is the one the reported margin arithmetic supports: EBITDA of ₹12.90 crore on ₹100.06 crore of revenue gives 12.89%, which matches the 12.90% margin as reported, whereas the lower base would imply a margin near 14.7% that nobody published. Readers reconciling against Screener directly should expect the difference.
Two observations follow. First, this is volume-led growth: revenue rose 34% while the EBITDA margin improved only about 60 basis points, so the company sold substantially more rather than simply repricing. That is the better kind of growth. Second, the 12.9% EBITDA margin sits below the 16.2% five-year average operating margin, which is a useful reminder that the current quarter is strong on volume rather than unusually rich on spread.
Trailing EPS of ₹3.32 across roughly 10.5277 crore shares implies annual profit near ₹35 crore, which reconciles sensibly with a June quarter of ₹9.08 crore.
Where the growth is plausibly coming from
We would rather describe the demand drivers structurally than claim a specific order book we cannot see. Vinyl flooring in India benefits from a few durable trends: hospitals and healthcare facilities specifying seamless hygienic floors, commercial fit-outs choosing resilient flooring over stone or carpet on cost and maintenance, and automotive and furniture demand for engineered leather cloth as an alternative to leather.
| Demand pool | Why it grows | What could interrupt it |
|---|---|---|
| Healthcare flooring | Hygiene specifications favour seamless vinyl | Public capex cycles are lumpy |
| Commercial interiors | Lower installed and lifecycle cost than alternatives | Office and retail construction slowdowns |
| Automotive interiors | Engineered leather substitutes at OEM scale | Vehicle production cycles and OEM sourcing shifts |
| Furniture and upholstery | Cost and consistency versus natural leather | Cheap imports and unorganised competition |
| Exports | Cost position and capacity availability | Currency, freight and trade measures |
None of these is proprietary to Premier Polyfilm. Its share of them depends on capacity, cost and customer relationships rather than on any structural protection, which is precisely why the valuation discussion below is careful.
The quality numbers are better than the business model suggests
| Quality measure | 6 August 2026 value | Reading |
|---|---|---|
| Return on equity | 24.05% | High for a polymer converter |
| Return on capital employed | 30.79% | Above the 26.00% five-year average |
| Operating margin | 16.21% | The through-cycle level to expect |
| Five-year sales CAGR | 14.70% | Steady rather than spectacular |
| Five-year profit CAGR | 30.54% | Operating leverage on a small base |
| Promoter pledge | 0% | No pledged holding at the cut-off |
A 30.8% return on capital from a converter is a genuinely good outcome, and it is running above its own five-year average, which tells you the cycle is currently favourable rather than that the business has been permanently re-rated. Assuming the current ROCE is the new normal would be the main way to get this wrong.
Valuation at the fixed price
At ₹72.58 the shares traded at about 21.9 times trailing earnings and 5.2 times book. The 52-week range ran from ₹38.00 to ₹85.34.
| Valuation metric | 6 August 2026 value | Basis |
|---|---|---|
| Share price | ₹72.58 | Exchange close on the cut-off date |
| Reconciled market capitalisation | ₹764 Cr | Price times about 10.5277 crore shares |
| Recalculated P/E | 21.86× | ₹72.58 divided by trailing EPS of ₹3.32 |
| Recalculated price to book | 5.17× | ₹72.58 divided by ₹14.05 book value per share |
| Recalculated PEG | About 0.72 | P/E divided by the 30.54% five-year profit CAGR |
| Dividend yield | About 0.21% | Token; earnings are retained |
| 52-week range | ₹38.00 – ₹85.34 | Cut-off price about 15% below the high |
Five times book for a converter is the number that deserves scrutiny. It is justified only while the return on equity stays in the mid-twenties. If margin reverts toward the 16% five-year average and ROE normalises into the high teens, both the earnings and the multiple would be under pressure at the same time — which is how cyclical de-ratings usually work.
The available valuation fields did not match the price we fixed, so market capitalisation, P/E, price to book, PEG and yield above were recomputed against the same ₹72.58 close and roughly 10.5277 crore shares.
Liquidity and size
This is a company worth under ₹800 crore, listed on both the BSE and the NSE. Daily traded value is modest, institutional coverage is minimal, and the price responds sharply to small changes in flow — the move from ₹38.00 to ₹85.34 inside a year is itself evidence of that. The practical implication is straightforward: the position size should assume that exiting during a poor market will be slower and more expensive than the screen suggests.
Valuation framework: pricing a good part of the cycle
The model compounds trailing EPS of ₹3.32 from the cut-off, applying 147/365 of a year’s growth to the 2026 row and one further full year to each later row, then an exit price-to-earnings multiple. Values round to the nearest ₹5 and exclude dividends. At this share price the rounding is coarse relative to the price, so the grid should be read as an indication of magnitude rather than to the rupee.
| Scenario | Annual EPS growth | Exit P/E | Operating interpretation |
|---|---|---|---|
| Bear | 10% | 15× | Spread normalises toward the five-year margin and the multiple compresses |
| Base | 17% | 21× | Volume growth continues at a moderated pace with stable spreads |
| Bull | 24% | 27× | Capacity and export demand extend the current run and the rating holds |
Premier Polyfilm share price target 2026 to 2030
The grid above resolves those assumptions into yearly values. For a cyclical converter the bear column carries more weight than usual, because a downturn compresses earnings and the multiple together rather than one at a time.
What would change the thesis
The case strengthens if revenue growth above 25% persists for several quarters, if the EBITDA margin moves back toward the 16% five-year level while volumes keep rising, if export revenue becomes a disclosed and growing share of the mix, and if capacity additions are funded from operating cash rather than debt.
It weakens if PVC resin costs rise sharply and the company cannot pass them through, if the June quarter proves to be a peak rather than a run rate, if return on capital drifts back toward the 26% five-year average while the shares still trade above five times book, or if competition from imports and unorganised producers compresses realisations.
Quarterly monitoring scorecard
| Question | Constructive evidence | Warning sign |
|---|---|---|
| Is volume growth continuing? | Revenue growth stays above 20% | Growth decelerates to single digits |
| Is the spread holding? | EBITDA margin moves toward 16% | Margin falls below 11% |
| Is growth volume-led? | Revenue rises faster than realisations | Growth depends on price alone |
| Is capital still productive? | ROCE stays near or above 30% | Drift back toward the 26% five-year mean |
| Is the balance sheet clean? | Expansion funded from operating cash | Borrowings rise to fund capacity |
| Is the cycle turning? | Input costs stable or falling | Resin costs rise faster than selling prices |
What to weigh at the current price
The recent record is hard to argue with. Revenue up 34%, profit up 51%, margin slightly better, return on capital above 30%, no pledge and no obvious balance sheet strain. On the trailing numbers the shares are not expensive relative to their own growth, with a PEG near 0.72.
The reservation is structural rather than immediate. This is a spread business in a cyclical input, currently earning above its own long-run margin, priced at roughly five times book. That combination works while the cycle cooperates and unwinds quickly when it does not. We think the growth is real enough to justify owning it, sized as the cyclical it is, with the explicit understanding that the 16.2% five-year operating margin — not the current quarter — is the number to plan around.
FAQ
What is the Premier Polyfilm share price target for 2030?
The grid above sets out bear, base and bull values from trailing EPS, an assumed growth rate and an exit multiple. Because the share price is low in absolute terms, the rounding is coarse and the range should be read as magnitude.
What does Premier Polyfilm manufacture?
Flexible PVC products — vinyl flooring, sheeting and artificial leather cloth — used in healthcare and commercial flooring, automotive and furniture interiors and a range of industrial applications.
How strong was Q1 FY27?
Revenue rose about 34.4% to roughly ₹100.06 crore and profit after tax rose about 51.3% to roughly ₹9.08 crore, with the EBITDA margin improving modestly to about 12.90%.
What is the biggest risk in Premier Polyfilm shares?
Input-cost cyclicality. The company buys PVC resin and sells finished sheet, so a sharp rise in polymer prices that cannot be passed through compresses margin directly, and the current return on capital is running above its five-year average.
Why does the price-to-book ratio matter here?
Because at roughly 5.2 times book the valuation depends on return on equity staying in the mid-twenties. If margin reverts to the long-run average, earnings and the multiple would likely fall together.
When does Premier Polyfilm report its next result?
Check the results calendar and confirm the board-meeting date from the company’s own exchange filing before relying on any estimate.
Related research
Sources and methodology
- Premier Polyfilm on Screener
- Premier Polyfilm Q1 FY27 results
- Premier Polyfilm Q1 profit and revenue report
- Premier Polyfilm Q1 FY27 result analysis
Return and margin metrics are Screener figures captured on 6 August 2026, with the price and 52-week range taken from exchange closing data for the same session; per-share ratios were recomputed against that single price. June-quarter figures are as reported and contemporaneously covered. Demand drivers are described structurally because we could not source a current disclosed order book or segment split, and no such breakdown has been implied above.
This article is research and education, not personalised investment advice or a recommendation to transact. Gale is not a SEBI-registered investment adviser. Price targets are scenario arithmetic, not promises. Verify current filings, liquidity, corporate actions and suitability, and consult a registered adviser before acting.